An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladder by Zhipeng Zhang, Deyi Luo, Zhong Chen, Peng Zhang, Ganping Zhong, Keji Xie, Zhuoqun Xu, Xudong Li, Jianye Wang, Yingfan Yang, Farid Abdul Hadi, Arianne Schild

Subjects: Get full text